Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc.

TMO

Market Cap$206.36B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Thermo Fisher Scientific Inc.Thermo Fisher Scientific Inc.34.20.27%-4.8-

Earnings Call Q1 2024

April 24, 2024 - AI Summary

Thermo Fisher Scientific had a strong start to the year, delivering another quarter of strong financial performance.
The company raised its 2024 guidance due to stronger operational performance in Q1 and expects revenue to be in the range of $42.3 billion to $43.3 billion, with adjusted EPS in the range of $21.14 to $22.02 per share.
Market conditions played out as expected, with improvements seen in the biotech funding environment and the stimulus program announced by China, supporting the view of a modest pickup in economic activity as the year progresses.

Exclusive for Stockcircle Pro members

Sign upSign Up
$623.75

Target Price by Analysts

16.7% upsideThermo Fisher Scientific Target Price DetailsTarget Price
$903.88

Current Fair Value

69.2% upside

Undervalued by 69.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$206.36 Billion
Enterprise Value-
Dividend Yield$1.4786 (0.27%)
Earnings per Share$15.59
Beta0.92
Outstanding Shares381,716,323
Avg 30 Day Volume1,789,759

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio34.2
PEG1130.36
Price to Sales4.81
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Thermo Fisher Scientific Inc.

75,000 employees
CEO: Marc Casper

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $25 billion. Its Mission is to enable our customers to make the world healthier, cleaner and safer. Whether the customers are acceleratin...